A clinical trial of the accuracy and treatment experience of the Dexcom G4 Sensor (Dexcom G4 System) and enlite sensor (Guardian REAL-Time System) tested simultaneously in ambulatory patients with type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 16, Issue 11, 2014, Pages 759-767

  Matuleviciene, Viktorija ^a   Joseph, Jeffrey ^b   Andelin, Mervi ^c   Hirsch, Irl B ^d   Attvall, Stig ^a   Pivodic, Aldina ^e   Dahlqvist, Sofia ^c   Klonoff, David ^f   Haraldsson, Börje ^a   Lind, Marcus ^a,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UDDEVALLA HOSPITAL   (Sweden)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Statistiska Konsultgruppen   (Sweden)

^f DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CAPILLARY BLOOD; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTINUOUS GLUCOSE MONITORING; CONTINUOUS INFUSION; DAILY LIFE ACTIVITY; DEXCOM G4 PLATINUM SENSOR; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; MEASUREMENT ACCURACY; PATIENT SATISFACTION; PERSONAL EXPERIENCE; REFERENCE VALUE; VISUAL ANALOG SCALE; BLOOD; COMPARATIVE STUDY; DEVICES; DIABETES MELLITUS, TYPE 1; EVALUATION STUDY; GENETIC PROCEDURES; MATERIALS TESTING; METABOLISM; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SWEDEN;

ADULT; AGED; BIOSENSING TECHNIQUES; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; MALE; MATERIALS TESTING; MIDDLE AGED; MONITORING, AMBULATORY; PATIENT SATISFACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SWEDEN;

EID: 84907214477     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0238     Document Type: Article

References (21)

1. Diabetes Control and Complications Trial Study Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
2. Nathan DM, Cleary PA, Backlund JY, et al.: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
3. Lind M, Bounias I, Olsson M, et al.: Glycaemic control and incidence of heart failure in 20, 985 patients with type 1 diabetes: an observational study. Lancet 2011;378:140-146.
4. Swedish National Diabetes Register. Annual Report 2012. www.ndr.nu/pdf/Annual-Report-NDR-2012.pdf (accessed January 9, 2014).
5. Livingstone SJ, Looker HC, Hothersall EJ, et al.: Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med 2012;9:e1001321.
6. Laing SP, Swerdlow AJ, Slater SD, et al.: The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999;1:459-465.
7. Skrivarhaug T, Bangstad HJ, Stene LC, et al.: Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006;49:298-305.
8. Secrest AM, Becker DJ, Kelsey SF, et al.: Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes 2010;59:3216-3222.
9. American Diabetes Association: Position statement: standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl 1):S14-S80.
10. Blevins TC, Bode BW, Garg SK, et al.: Statement by the American Association of Clinical Endocrinologists Consensus Panel on Continuous Glucose Monitoring. Endocr Pract 2010;16:730-745.
11. Heinemann L, Franc S, Phillip M, et al.: Reimbursement for continuous glucose monitoring: a European view. J Diabetes Sci Technol 2012;6:1498-1502.
12. Kovatchev B, Anderson S, Heinemann L, et al.: Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care 2008;31: 1160-1164.
13. Damiano ER, McKeon K, El-Khatib FH, et al.: A comparative effectiveness analysis of three continuous glucose monitors: the Navigator, G4 Platinum and Enlite. J Diabetes Sci Technol 2014;8:699-708.
14. Keenan DB, Mastrototaro JJ, Zisser H, et al.: Accuracy of the Enlite 6-day glucose sensor with Guardian and Veo calibration algorithms. Diabetes Technol Ther 2012;14:225-231.
15. Calhoun P, Lum J, Beck RW, et al.: Performance comparison of the Medtronic Sof-Sensor and Enlite glucose sensors in inpatient studies of individuals with type 1 diabetes. Diabetes Technol Ther 2013;15:758-761.
16. Damiano ER, El-Khatib FH, Magyar KL, et al.: A comparative analysis of three continuous glucose monitors: not all are created equal [abstract]. Diabetes 2012;61(Suppl 1):A2.
17. Rodbard D: Characterizing accuracy and precision of glucose sensors and meters. J Diabetes Sci Technol 2014;8:980-985.
18. Hannestad U, Lundblad A: Accurate and precise isotope dilution mass spectrometry method for determining glucose in whole blood. Clin Chem 1997;43:794-800.
19. Borg R, Kuenen JC, Carstensen B, et al.: Associations between features of glucose exposure and A1C: the A1CDerived Average Glucose (ADAG) study. Diabetes 2010;59: 1585-1590.
20. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, et al.: Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009;32:1947-1953.
21. Bergenstal RM, Tamborlane WV, Ahmann A, et al.: Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-320.